TerminatedNCT03242772
Impact of Combined Medication and Behavioral Treatment for ASD & ADHD
Medication studyAges 36–131 monthsUnited States
Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 36 months to 131 months. Other eligibility criteria apply.
- Listed locations
- DurhamSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 14, 2018
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 18
- Sponsor
- Duke University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 36 Months to 131 Months
- Official registry ID
- NCT03242772
- Official title
Show the full official title
Impact of Combined Medication and Behavioral Treatment in Young Children With Comorbid ASD and ADHD
Recruitment & locations
TerminatedDurham
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Duke University, a university.
Does this study involve medication?
Yes. The study involves medication, including Amphetamine and Placebo Oral Tablet.
Who can participate?
This study is for people with ADHD. Listed age limits: 36 months to 131 months. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
